BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22112547)

  • 1. AβPP accumulation and/or intraneuronal amyloid-β accumulation? The 3xTg-AD mouse model revisited.
    Wirths O; Dins A; Bayer TA
    J Alzheimers Dis; 2012; 28(4):897-904. PubMed ID: 22112547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Verkhratsky A; Rodríguez JJ
    Aging Cell; 2012 Oct; 11(5):810-22. PubMed ID: 22702392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.
    Soejima N; Ohyagi Y; Nakamura N; Himeno E; Iinuma KM; Sakae N; Yamasaki R; Tabira T; Murakami K; Irie K; Kinoshita N; LaFerla FM; Kiyohara Y; Iwaki T; Kira J
    Curr Alzheimer Res; 2013 Jan; 10(1):11-20. PubMed ID: 22950910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
    Winton MJ; Lee EB; Sun E; Wong MM; Leight S; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2011 May; 31(21):7691-9. PubMed ID: 21613482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice.
    Lopez JR; Lyckman A; Oddo S; Laferla FM; Querfurth HW; Shtifman A
    J Neurochem; 2008 Apr; 105(1):262-71. PubMed ID: 18021291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease.
    Capetillo-Zarate E; Gracia L; Tampellini D; Gouras GK
    Neurodegener Dis; 2012; 10(1-4):56-9. PubMed ID: 22269167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canines.
    Nuntagij P; Oddo S; LaFerla FM; Kotchabhakdi N; Ottersen OP; Torp R
    J Alzheimers Dis; 2009; 16(2):315-23. PubMed ID: 19221421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
    Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
    J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early increases in soluble amyloid-β levels coincide with cholinergic degeneration in 3xTg-AD mice.
    Girão da Cruz MT; Jordão J; Dasilva KA; Ayala-Grosso CA; Ypsilanti A; Weng YQ; Laferla FM; McLaurin J; Aubert I
    J Alzheimers Dis; 2012; 32(2):267-72. PubMed ID: 22776965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
    Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
    J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody.
    Youmans KL; Tai LM; Kanekiyo T; Stine WB; Michon SC; Nwabuisi-Heath E; Manelli AM; Fu Y; Riordan S; Eimer WA; Binder L; Bu G; Yu C; Hartley DM; LaDu MJ
    Mol Neurodegener; 2012 Mar; 7():8. PubMed ID: 22423893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
    Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
    Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology?
    Bayer TA; Wirths O
    Biochem Soc Trans; 2011 Aug; 39(4):857-61. PubMed ID: 21787313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
    Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
    Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease.
    Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT
    J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.
    Jawhar S; Trawicka A; Jenneckens C; Bayer TA; Wirths O
    Neurobiol Aging; 2012 Jan; 33(1):196.e29-40. PubMed ID: 20619937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.